uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
24.88
+0.37
(+1.51%)
Pre-Market: 08:38
uniQure Price : 24.51 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | 23.85 | 26.00 | 22.47 | 24.51 | 29.81M |
| Sep 28, 2026 | 37.65 | 39.66 | 37.18 | 39.11 | 1.853M |
| Sep 25, 2026 | 38.20 | 39.12 | 37.62 | 38.23 | 1.177M |
| Sep 24, 2026 | 42.42 | 42.87 | 36.82 | 38.32 | 4.238M |
| Sep 23, 2026 | 45.17 | 45.41 | 42.62 | 42.76 | 1.174M |
| Sep 22, 2026 | 44.50 | 45.80 | 44.47 | 45.28 | 1.145M |
| Sep 21, 2026 | 44.50 | 45.02 | 43.81 | 44.31 | 801233.0 |
| Sep 18, 2026 | 44.40 | 44.52 | 43.56 | 44.00 | 2.099M |
| Sep 17, 2026 | 43.47 | 44.58 | 43.00 | 44.09 | 799172.0 |
| Sep 16, 2026 | 43.40 | 43.73 | 41.67 | 42.49 | 1.470M |
| Sep 15, 2026 | 44.73 | 44.82 | 42.58 | 43.10 | 1.216M |
| Sep 14, 2026 | 44.27 | 45.75 | 44.05 | 44.93 | 709629.0 |
| Sep 11, 2026 | 44.66 | 45.30 | 44.04 | 44.51 | 1.242M |
| Sep 10, 2026 | 45.68 | 45.82 | 44.40 | 44.47 | 923239.0 |
| Sep 09, 2026 | 45.71 | 46.98 | 45.37 | 46.00 | 1.355M |
| Sep 08, 2026 | 43.38 | 46.25 | 43.05 | 45.68 | 1.397M |
| Sep 04, 2026 | 44.91 | 45.16 | 43.90 | 44.50 | 991476.0 |
| Sep 03, 2026 | 45.50 | 46.03 | 44.03 | 44.86 | 1.322M |
| Sep 02, 2026 | 50.72 | 50.97 | 45.25 | 46.23 | 2.486M |
| Sep 01, 2026 | 48.63 | 48.85 | 47.29 | 47.86 | 748863.0 |
| Aug 31, 2026 | 48.23 | 48.86 | 47.59 | 48.68 | 1.643M |
| Aug 28, 2026 | 49.51 | 49.51 | 48.29 | 48.72 | 843706.0 |
| Aug 27, 2026 | 50.83 | 51.03 | 49.51 | 49.56 | 779435.0 |
| Aug 26, 2026 | 50.90 | 51.20 | 50.05 | 50.95 | 900789.0 |
| Aug 25, 2026 | 48.00 | 51.72 | 47.92 | 51.05 | 2.190M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Kymera Therapeutics, Inc. | 110.51 |
| Sarepta Therapeutics, Inc. | 18.64 |
| Twist Bioscience Corp. | 186.13 |
| GRAIL, Inc. | 136.57 |
| Arrowhead Pharmaceuticals, Inc. | 66.25 |
Price Related Metrics
| PS Ratio | 81.99 |
| PEG Ratio | -1.865 |
| Price to Book Value | 5.244 |
| Earnings Yield | -16.52% |
| Market Cap | 1.699B |
| PEGY Ratio | -1.865 |